James Vollins - Apr 30, 2023 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Role
General Counsel
Signature
/s/ James Vollins
Stock symbol
EIGR
Transactions as of
Apr 30, 2023
Transactions value $
$0
Form type
4
Date filed
5/2/2023, 04:30 PM
Previous filing
Apr 14, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +120K $0.00 120K Apr 30, 2023 Common Stock 120K $1.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to twenty-five percent of the shares upon the one-year anniversary of April 12, 2023, and in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service status as of each such date.